Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fenretinide in Treating Patients With Recurrent Malignant Glioma

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00006080
First received: August 3, 2000
Last updated: November 22, 2008
Last verified: September 2005